ClinicalTrials.govpublic full text
Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer
metastatic triple negative breast cancer, triple negative breast cancer (tnbc), veliparib, lapatinib, estrogen receptor negative, progesterone receptor negative, (her-2-neu) negative, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910104
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.